Non-statin lipid-lowering therapy over time in very-high-risk patients: effectiveness of fixed-dose statin/ezetimibe compared to separate pill combination on LDL-C
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1861-0692
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Non-statin lipid-lowering therapy over time in very-high-risk patients: effectiveness of fixed-dose statin/ezetimibe compared to separate pill combination on LDL-C ; day:19 ; month:9 ; year:2020 ; pages:1-10
Clinical research in cardiology ; (19.9.2020), 1-10
- Creator
-
Katzmann, Julius Ludwig
Sorio-Vilela, Francesc
Dornstauder, Eugen
Fraas, Uwe
Smieszek, Timo
Zappacosta, Sofia
Laufs, Ulrich
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00392-020-01740-8
- URN
-
urn:nbn:de:101:1-2020110812441009388765
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Katzmann, Julius Ludwig
- Sorio-Vilela, Francesc
- Dornstauder, Eugen
- Fraas, Uwe
- Smieszek, Timo
- Zappacosta, Sofia
- Laufs, Ulrich
- SpringerLink (Online service)
Other Objects (12)
Adherence to Lipid-Lowering Treatment by Single-Pill Combination of Statin and Ezetimibe
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Role of non-statin lipid-lowering therapy in coronary atherosclerosis regression: a meta-analysis and meta-regression
Factors explaining the gender disparity in lipid-lowering treatment goal attainment rate in Chinese patients with statin therapy
Efficacy and safety of alirocumab in patients with hypercholesterolemia not adequately controlled with non-statin lipid-lowering therapy or the lowest strength of statin: ODYSSEY NIPPON study design and rationale
A clinical trial to evaluate the effect of statin use on lowering aldosterone levels
Statin Intolerance: Diagnosis and Management
Genetic determinants of statin intolerance
Pazopanib and Statin-Induced Rhabdomyolysis
Alirocumab vs usual lipid‐lowering care as add‐on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM‐DYSLIPIDEMIA randomized trial
Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers
Hyperlipidemia, statin use and dengue severity
Adherence to Lipid-Lowering Treatment by Single-Pill Combination of Statin and Ezetimibe
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Role of non-statin lipid-lowering therapy in coronary atherosclerosis regression: a meta-analysis and meta-regression
Factors explaining the gender disparity in lipid-lowering treatment goal attainment rate in Chinese patients with statin therapy
Efficacy and safety of alirocumab in patients with hypercholesterolemia not adequately controlled with non-statin lipid-lowering therapy or the lowest strength of statin: ODYSSEY NIPPON study design and rationale
A clinical trial to evaluate the effect of statin use on lowering aldosterone levels
Statin Intolerance: Diagnosis and Management
Genetic determinants of statin intolerance
Pazopanib and Statin-Induced Rhabdomyolysis
Alirocumab vs usual lipid‐lowering care as add‐on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM‐DYSLIPIDEMIA randomized trial
Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers
Hyperlipidemia, statin use and dengue severity
Adherence to Lipid-Lowering Treatment by Single-Pill Combination of Statin and Ezetimibe
Glycaemic Effects of Non-statin Lipid-Lowering Therapies
Role of non-statin lipid-lowering therapy in coronary atherosclerosis regression: a meta-analysis and meta-regression
Factors explaining the gender disparity in lipid-lowering treatment goal attainment rate in Chinese patients with statin therapy
Efficacy and safety of alirocumab in patients with hypercholesterolemia not adequately controlled with non-statin lipid-lowering therapy or the lowest strength of statin: ODYSSEY NIPPON study design and rationale
A clinical trial to evaluate the effect of statin use on lowering aldosterone levels
Statin Intolerance: Diagnosis and Management
Genetic determinants of statin intolerance
Pazopanib and Statin-Induced Rhabdomyolysis
Alirocumab vs usual lipid‐lowering care as add‐on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM‐DYSLIPIDEMIA randomized trial
Comparison of statin plus ezetimibe with double-dose statin on lipid profiles and inflammation markers